Рет қаралды 28,361
Scleroderma is a challenging disease to treat. Doctors have figured out good ways to address the complications, but what about therapies to treat the underlying disease? Rheumatologist Robert Spiera, MD, describes a new possible strategy that takes aim at B cells. The therapy is currently being studied through a clinical trial.
Learn more about Scleroderma: www.hss.edu/conditions_sclero...
CONNECT with HSS
Facebook: hspecialsurgery
Twitter: hspecialsurgery
Instagram: hspecialsurgery
Request an appointment at HSS by calling 888.720.1977 or online at www.hss.edu/appointment